 |
|
|
 |
Arsenic Trioxide - Ascorbic Acid: Promising Treatment Strategy For Acute Myelogenous Leukemia (AML)
A report published in the British Journal of Haematology demonstrated enhanced killing effects against leukemia cells isolated from patients with acute myelogenous leukemia (AML) when treated with a combination of arsenic trioxide and ascorbic acid. The authors concluded that additional studies on the combination of arsenic trioxide and ascorbic acid are warranted. more
|
|
Over 70 Percent of Children Visit A Doctor's Office At Least Once During the Year
Over 70 percent of all children under age 18 had at least one office visit for health care during 1996. In contrast, only 7.2 percent had a hospital outpatient visit and less than 3 percent experienced an inpatient stay (excluding stays for normal birth). more
|
|
|
|
Higher Order Multiple Births Drop For First Time In A Decade
Triplet and other higher order multiple births (triplet/+) declined in 1999 for the first time in a decade after more than doubling between 1990 and 1998, according to the latest natality statistics released in a report today by the Centers for Disease Control and Prevention (CDC). more
|
|
Study Shows Promising Treatment For Women With Low Sex Drive
A study published in the May-June issue of the Journal of Sex and Marital Therapy found that bupropion hydrochloride sustained-release tablets may be an effective treatment for hypoactive sexual desire disorder (HSDD) in females, a deficiency or absence of sexual desire and fantasies for sexual activity. more
|
|
MicroMed DeBakey VAD Granted Pivotal Trial Approval By FDA
MicroMed Technology, Inc. today announced it has received conditional approval from the Food and Drug Administration (FDA) to begin its pivotal multi-center clinical study of the MicroMed DeBakey Ventricular Assist Device (VAD). The clinical trial will take place at approximately 20 sites with an estimated 178 treated and control subjects. more
|
|
|
